The Third Annual Genomics and Ethics Symposium will explore ethical and clinical issues related to genomic sequencing technologies, such as informed consent for genomic sequencing; disclosure of genomic sequencing results; and the impact of genomic sequencing results on patients, their families and clinicians. 

As genomic sequencing advances in clinical medicine, a myriad of ethical questions are being raised and demand thoughtful responses. These questions, such as which test results should be disclosed, and how might results impact patients and their families, have no easy answers, yet clinicians, researchers and the general public will need to know how to best respond to these and many other ethical questions. Dissemination of new knowledge and best practices for addressing and managing ethical concerns raised by the clinical application of new genetic technologies to key stakeholders including clinicians, researchers, health care providers, and the public are crucial to the advancement of genetic sequencing in clinical medicine.

This symposium will serve as an interdisciplinary workshop on genetics and ethics in order to present and discuss the latest empirical research results and promote continued refinement of the best practices for addressing and managing the ethical concerns of genetic sequencing to the aforementioned key stakeholders. 

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Medical College of Wisconsin designates this activity for up to 5.75 hours of participation for continuing education for allied health professionals.